1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (7820)
  2. Meeting Abstract (3612)
  3. Review (610)
  4. Editorial (251)
  5. Book Section (189)
  6. Conference Paper (160)
  7. Research Letter (133)
  8. Correspondence (63)
  9. Miscellaneous (62)
  10. Guidelines (30)
  11. Book Whole (6)
Groups
  1. Sloan Kettering Institute Postdocs (12936)
  2. GSK Faculty (6210)
  3. Department of Medicine (4656)
  4. Sloan Kettering Institute Faculty (3490)
  5. Surgery (2557)
  6. Solid Tumor Oncology Division (2525)

More Groups

People
  1. Britta Weigelt (366)
  2. Jorge Reis-Filho (327)
  3. Mithat Gonen (309)
  4. Marc Ladanyi (304)
  5. Joseph Deasy (278)
  6. Michael Berger (278)

More People

Years
  1. 2025 (394)
  2. 2024 (1038)
  3. 2023 (1151)
  4. 2022 (1364)
  5. 2021 (1176)
  6. 2020 (1240)

More Years

Publications
  1. Blood (641)
  2. Cancer Research (542)
  3. Journal of Clinical Oncology (416)
  4. Journal of Nuclear Medicine (261)
  5. Annals of Surgical Oncology (257)
  6. Clinical Cancer Research (235)

More Publications

Publishers
  1. Nature Publishing Group (1308)
  2. Elsevier Inc. (1173)
  3. American Association for Cancer Research (1039)
  4. Springer (818)
  5. Cell Press (719)
  6. American Society of Hematology (697)

More Publishers

Results (12936)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Reflux, Barrett’s esophagus, and esophageal adenocarcinoma after bariatric surgery
    Journal Article

    Medina, B.; Molena, D.
    Foregut (2021)

    Fulltext@MSK | Save
  • The role of HIPEC in the treatment of ovarian cancer
    Book Section

    Boerner, T.; Oseledchyk, A.; Zivanovic, O.
    In Rau, B.; Königsrainer, A.; Mohamed, F.; Sugarbaker, P. H. (Eds.) Peritoneal Tumors and Metastases: Surgical, intraperitoneal and systemic therapy (2021)

    Fulltext@MSK | Save
  • Radiopharmaceuticals in oncology
    Book Section

    Goos, J. A. C. M.; Keinänen, O.; Zeglis, B. M.; Lewis, J. S.
    In Kilbourn, M. R.; Scott, P. J. H. (Eds.) Handbook of Radiopharmaceuticals: Methodology and Applications. 2nd ed (2021)

    Fulltext@MSK | Save
  • Protease inhibitor plasma concentrations associate with COVID-19 infection
    Journal Article

    Medjeral-Thomas, N. R.; Troldborg, A.; Hansen, A. G.; Pihl, R.; Clarke, C. L.; Peters, J. E.; Thomas, D. C.; Willicombe, M.; Palarasah, Y.; Botto, M.; more...
    Oxford Open Immunology (2021)

    Fulltext@MSK | Save
  • Pathophysiology and molecular research in lymphedema
    Book Section

    Mehrara, B. J.; Dayan, J. H.; Coriddi, M.; Kataru, R. P.
    In Cheng, M. H.; Chang, D. W.; Patel, K. M. (Eds.) Principles and Practice of Lymphedema Surgery. 2nd ed (2021)

    Fulltext@MSK | Save
  • Surgery for benign salivary gland tumors: Classic approaches
    Book Section

    Karassawa Zanoni, D.; Patel, S. G.; Kahane, J.; Wang, R. C.; Deschler, D.; Zenga, J.; Dias, F. L.; Cernea, C. R.; Lima, R. A.
    In Witt, R. L. (Eds.) Surgery of the Salivary Glands (2021)

    Fulltext@MSK | Save
  • Highly selective irreversible ITK inhibitor Cpi-818 reduces acute graft-versus host disease
    Meeting Abstract

    Lindner, S.; Lee, N.; Armijo, G. K.; Burgos da Silva, Marina; Herrera, P. S.; Nguyen, C. L.; Dwomoh, E. A.; Ghale, R.; Smith, M.; Perales, M. A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Zanubrutinib, obinutuzumab, and venetoclax in chronic lymphocytic leukemia: Early MRD kinetics define a high-risk patient cohort with delayed bone marrow undetectable MRD and earlier post-treatment MRD recurrence
    Meeting Abstract

    Soumerai, J. D.; Mato, A. R.; Dogan, A.; Seshan, V.; Joffe, E.; Flaherty, K.; Carter, J.; Hochberg, E. P.; Barnes, J. A.; Hamilton, A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Whole transcriptome analysis identifies distinct gene expression profiles between SF3B1(mut) and SF3B1(wt) myelodysplastic syndrome with ring sideroblasts
    Meeting Abstract

    Todisco, G.; Creignou, M.; Bernard, E.; Björklund, A. C.; Moura, P. L.; Jansson, M.; Chang, D.; Venckute, S.; Walldin, G.; Malcovati, L.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Quantitative change in metabolic tumor volume may assist in distinguishing between pseudoprogressors and responders in patients with relapsed/refractory classical Hodgkin lymphoma treated with PD-1 blockade
    Meeting Abstract

    Wills, B.; Michaud, L.; Schöder, H.; Ganesan, N.; Moskowitz, C. H.; Straus, D. J.; Falchi, L.; Matasar, M. J.; Zelenetz, A. D.; Joffe, E.; more...
    Blood (2021)

    Fulltext@MSK | Save